⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IRON News

Disc Medicine, Inc. Common Stock

Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)